e-SiHLE: An Internet Pregnancy Prevention for Older Teenage Girls

NCT ID: NCT01579617

Last Updated: 2016-12-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

637 participants

Study Classification

INTERVENTIONAL

Study Start Date

2012-08-31

Study Completion Date

2015-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to evaluate the efficacy of an online pregnancy prevention intervention that was adapted from the evidence based small group intervention SiHLE.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The investigators will test the hypothesis that by the end of the study, women who receive the e-SIHLE intervention will have a 35% increase in reliable contraception use compared to attention control website, DIVAS, which is a health and nutrition education program.

Both arms of the study were designed for African-American women who are 18-19 years old.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pregnancy Sexually Transmitted Infections

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

pregnancy STI STD

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

BUtiful

Intervention arm, 'BUtiful. Be yoU! Talented, Informed, Fearless, Uncompromised, Loved', has 8 website sessions focused on pregnancy and STI prevention

Group Type EXPERIMENTAL

BUtiful.

Intervention Type BEHAVIORAL

8 website sessions include themes that teach: gender empowerment, assertive communication skills, goal setting, pregnancy and STI/HIV risk, safer sex behaviors, proper condom use, positive attitudes and norms towards consistent condom use, contraception, partner involvement in safer sex, and responsibility for their own health.

DIVAS

Attention control arm, 'DIVAS. Diversity, Individuality, Vitality, Activity and Strong', has 8 website sessions focused on general health and nutrition

Group Type OTHER

DIVAS.

Intervention Type BEHAVIORAL

Attention control arm: 8 website sessions that include topics on: healthy eating, choosing nutritional snacks, sugar and salt intake, physical activity, stress management, foods for beauty.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

BUtiful.

8 website sessions include themes that teach: gender empowerment, assertive communication skills, goal setting, pregnancy and STI/HIV risk, safer sex behaviors, proper condom use, positive attitudes and norms towards consistent condom use, contraception, partner involvement in safer sex, and responsibility for their own health.

Intervention Type BEHAVIORAL

DIVAS.

Attention control arm: 8 website sessions that include topics on: healthy eating, choosing nutritional snacks, sugar and salt intake, physical activity, stress management, foods for beauty.

Intervention Type BEHAVIORAL

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

BUtiful DIVAS

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age 18 or 19 at enrollment
* Female
* Not currently pregnant or intending to become pregnant in the next 12 months
* Live in Orleans or Jefferson Parish in Louisiana
* English is your primary language
* Access to a computer and internet connection
* Does not have sex with women exclusively

Exclusion Criteria

* Age younger than 18 or older than 19
* Male
* Currently pregnant or intend to become pregnant in the next 12 months
* Live outside of Orleans or Jefferson Parish
* Hearing impairments that prevent listening to videos
Minimum Eligible Age

18 Years

Maximum Eligible Age

19 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Department of Health and Human Services

FED

Sponsor Role collaborator

Tulane University Health Sciences Center

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Patricia Kissinger

Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Patricia Kissinger, BSN MPH PhD

Role: PRINCIPAL_INVESTIGATOR

Tulane University Health Sciences Center, School of Public Health and Tropical Medicine

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Community Intercept

New Orleans, Louisiana, United States

Site Status

Tulane Drop In Clinic at Covenant House

New Orleans, Louisiana, United States

Site Status

Delgado Community College

New Orleans, Louisiana, United States

Site Status

Dillard University

New Orleans, Louisiana, United States

Site Status

Xavier University

New Orleans, Louisiana, United States

Site Status

Southern University of New Orleans

New Orleans, Louisiana, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

References

Explore related publications, articles, or registry entries linked to this study.

Singh S, Darroch JE. Adolescent pregnancy and childbearing: levels and trends in developed countries. Fam Plann Perspect. 2000 Jan-Feb;32(1):14-23.

Reference Type BACKGROUND
PMID: 10710702 (View on PubMed)

Kost, K., Henshaw, S., & Carlin, L. , U.S. Teenage Pregnancies, Births and Abortions: National and State Trends and Trends by Race and Ethnicity. . 2010, Guttmacher: New York.

Reference Type BACKGROUND

Guttmacher Institute, Facts on American Teens' Sexual and Reproductive Health. 2010, Guttmacher Institute New York.

Reference Type BACKGROUND

Guttmacher Institute, U.S. Teenage Pregnancy Statistics: National and State Trends and Trends by Race and Ethnicity. . 2006, Guttmacher Institute: New York.

Reference Type BACKGROUND

Prevention, C.f.D.C.a., Youth Risk Behavior Surveillance Survey. 2007, Centers for Disease Control and Prevention

Reference Type BACKGROUND

Hamilton, B.E., Martin, J. A., & Ventura, S. J., National Vital Statistics Reports. 2007, Centers for Disease Control and Prevention.

Reference Type BACKGROUND

Mosher WD, Martinez GM, Chandra A, Abma JC, Willson SJ. Use of contraception and use of family planning services in the United States: 1982-2002. Adv Data. 2004 Dec 10;(350):1-36.

Reference Type BACKGROUND
PMID: 15633582 (View on PubMed)

Foundation, T.A.E.C., Kids Count 2008 data book 2008, The Annie E. Casey Foundation Baltimore.

Reference Type BACKGROUND

Frost JJ, Darroch JE. Factors associated with contraceptive choice and inconsistent method use, United States, 2004. Perspect Sex Reprod Health. 2008 Jun;40(2):94-104. doi: 10.1363/4009408.

Reference Type BACKGROUND
PMID: 18577142 (View on PubMed)

Finer LB, Henshaw SK. Disparities in rates of unintended pregnancy in the United States, 1994 and 2001. Perspect Sex Reprod Health. 2006 Jun;38(2):90-6. doi: 10.1363/psrh.38.090.06.

Reference Type BACKGROUND
PMID: 16772190 (View on PubMed)

Zill, N., & O'Donnell, K., Child poverty rates by maternal risk factors: An update. 2004, WESTAT.

Reference Type BACKGROUND

Martin JA, Hamilton BE, Sutton PD, Ventura SJ, Menacker F, Kirmeyer S, Munson ML; Centers for Disease Control and Prevention National Center for Health Statistics National Vital Statistics System. Births: final data for 2005. Natl Vital Stat Rep. 2007 Dec 5;56(6):1-103.

Reference Type BACKGROUND
PMID: 18277471 (View on PubMed)

Hoffman, S.D., By the numbers: The public costs of adolescent childbearing. 2006, The National Campaign to Prevent Teen Pregnancy.: Washington, DC.

Reference Type BACKGROUND

The National Campaign to Prevent Teen Pregnancy, Why it matters: Linking teen pregnancy prevention to other critical social issues. 2010: Washington, DC.

Reference Type BACKGROUND

Kissinger P, Clark R, Rice J, Kutzen H, Morse A, Brandon W. Evaluation of a program to remove barriers to public health care for women with HIV infection. South Med J. 1995 Nov;88(11):1121-5. doi: 10.1097/00007611-199511000-00007.

Reference Type BACKGROUND
PMID: 7481982 (View on PubMed)

Bedimo AL, Bessinger R, Kissinger P. Reproductive choices among HIV-positive women. Soc Sci Med. 1998 Jan;46(2):171-9. doi: 10.1016/s0277-9536(97)00157-3.

Reference Type BACKGROUND
PMID: 9447641 (View on PubMed)

Fuller C, Clark RA, Kissinger P, Abdalian SE. Clinical manifestations of infection with human immunodeficiency virus among adolescents in Louisiana. J Adolesc Health. 1996 Jun;18(6):422-8. doi: 10.1016/1054-139X(95)00235-K.

Reference Type BACKGROUND
PMID: 8803734 (View on PubMed)

Bessinger R, Clark R, Kissinger P, Rice J, Coughlin S. Pregnancy is not associated with the progression of HIV disease in women attending an HIV outpatient program. Am J Epidemiol. 1998 Mar 1;147(5):434-40. doi: 10.1093/oxfordjournals.aje.a009468.

Reference Type BACKGROUND
PMID: 9525529 (View on PubMed)

Kissinger P, Fuller C, Clark RA, Abdalian SE. Psychosocial characteristics of HIV-infected adolescents in New Orleans. J Adolesc Health. 1997 Apr;20(4):258. doi: 10.1016/S1054-139X(97)00029-3. No abstract available.

Reference Type BACKGROUND
PMID: 9098727 (View on PubMed)

Kissinger P, Mohammed H, Richardson-Alston G, Leichliter JS, Taylor SN, Martin DH, Farley TA. Patient-delivered partner treatment for male urethritis: a randomized, controlled trial. Clin Infect Dis. 2005 Sep 1;41(5):623-9. doi: 10.1086/432476. Epub 2005 Jul 19.

Reference Type BACKGROUND
PMID: 16080084 (View on PubMed)

Kissinger P, Schmidt N, Mohammed H, Leichliter JS, Gift TL, Meadors B, Sanders C, Farley TA. Patient-delivered partner treatment for Trichomonas vaginalis infection: a randomized controlled trial. Sex Transm Dis. 2006 Jul;33(7):445-50. doi: 10.1097/01.olq.0000204511.84485.4c.

Reference Type BACKGROUND
PMID: 16531939 (View on PubMed)

Schillinger JA, Kissinger P, Calvet H, Whittington WL, Ransom RL, Sternberg MR, Berman SM, Kent CK, Martin DH, Oh MK, Handsfield HH, Bolan G, Markowitz LE, Fortenberry JD. Patient-delivered partner treatment with azithromycin to prevent repeated Chlamydia trachomatis infection among women: a randomized, controlled trial. Sex Transm Dis. 2003 Jan;30(1):49-56. doi: 10.1097/00007435-200301000-00011.

Reference Type BACKGROUND
PMID: 12514443 (View on PubMed)

Kissinger P, Brown R, Reed K, Salifou J, Drake A, Farley TA, Martin DH. Effectiveness of patient delivered partner medication for preventing recurrent Chlamydia trachomatis. Sex Transm Infect. 1998 Oct;74(5):331-3. doi: 10.1136/sti.74.5.331.

Reference Type BACKGROUND
PMID: 10195027 (View on PubMed)

Kissinger, P., et al. Recurrent Trichomonas vaginalis among HIV positive and negative women. in 16th ISSTDR. 2005. Amsterdam, Netherlands.

Reference Type BACKGROUND

Kissinger P, Amedee A, Clark RA, Dumestre J, Theall KP, Myers L, Hagensee ME, Farley TA, Martin DH. Trichomonas vaginalis treatment reduces vaginal HIV-1 shedding. Sex Transm Dis. 2009 Jan;36(1):11-6. doi: 10.1097/OLQ.0b013e318186decf.

Reference Type BACKGROUND
PMID: 19008776 (View on PubMed)

Kissinger P, Secor WE, Leichliter JS, Clark RA, Schmidt N, Curtin E, Martin DH. Early repeated infections with Trichomonas vaginalis among HIV-positive and HIV-negative women. Clin Infect Dis. 2008 Apr 1;46(7):994-9. doi: 10.1086/529149.

Reference Type BACKGROUND
PMID: 18444815 (View on PubMed)

Chaturvedi AK, Dumestre J, Gaffga AM, Mire KM, Clark RA, Braly PS, Dunlap K, Beckel TE, Hammons AF, Kissinger PJ, Hagensee ME. Prevalence of human papillomavirus genotypes in women from three clinical settings. J Med Virol. 2005 Jan;75(1):105-13. doi: 10.1002/jmv.20244.

Reference Type BACKGROUND
PMID: 15543579 (View on PubMed)

Magnus M, Schillinger JA, Fortenberry JD, Berman SM, Kissinger P. Partner age not associated with recurrent Chlamydia trachomatis infection, condom use, or partner treatment and referral among adolescent women. J Adolesc Health. 2006 Sep;39(3):396-403. doi: 10.1016/j.jadohealth.2006.01.005. Epub 2006 Jul 10.

Reference Type BACKGROUND
PMID: 16919802 (View on PubMed)

Kissinger P, Clark R, Dumestre J, Bessinger R. Incidence of three sexually transmitted diseases during a safer sex promotion program for HIV-infected women. J Gen Intern Med. 1996 Dec;11(12):750-2. doi: 10.1007/BF02598989.

Reference Type BACKGROUND
PMID: 9016422 (View on PubMed)

Yoo S, Johnson CC, Rice J, Manuel P. A qualitative evaluation of the Students of Service (SOS) program for sexual abstinence in Louisiana. J Sch Health. 2004 Oct;74(8):329-34. doi: 10.1111/j.1746-1561.2004.tb06623.x.

Reference Type BACKGROUND
PMID: 15554119 (View on PubMed)

Card JJ, Kuhn T, Solomon J, Benner TA, Wingood GM, DiClemente RJ. Translating an effective group-based HIV prevention program to a program delivered primarily by a computer: methods and outcomes. AIDS Educ Prev. 2011 Apr;23(2):159-74. doi: 10.1521/aeap.2011.23.2.159.

Reference Type BACKGROUND
PMID: 21517664 (View on PubMed)

Latham TP, Sales JM, Boyce LS, Renfro TL, Wingood GM, DiClemente RJ, Rose E. Application of ADAPT-ITT: adapting an evidence-based HIV prevention intervention for incarcerated African American adolescent females. Health Promot Pract. 2010 May;11(3 Suppl):53S-60S. doi: 10.1177/1524839910361433.

Reference Type BACKGROUND
PMID: 20488969 (View on PubMed)

Wingood GM, DiClemente RJ. The ADAPT-ITT model: a novel method of adapting evidence-based HIV Interventions. J Acquir Immune Defic Syndr. 2008 Mar 1;47 Suppl 1:S40-6. doi: 10.1097/QAI.0b013e3181605df1.

Reference Type BACKGROUND
PMID: 18301133 (View on PubMed)

DiClemente RJ, Wingood GM, Harrington KF, Lang DL, Davies SL, Hook EW 3rd, Oh MK, Crosby RA, Hertzberg VS, Gordon AB, Hardin JW, Parker S, Robillard A. Efficacy of an HIV prevention intervention for African American adolescent girls: a randomized controlled trial. JAMA. 2004 Jul 14;292(2):171-9. doi: 10.1001/jama.292.2.171.

Reference Type BACKGROUND
PMID: 15249566 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

TP2AH000013

Identifier Type: OTHER_GRANT

Identifier Source: secondary_id

261904-1

Identifier Type: -

Identifier Source: org_study_id